| 标题 |
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Chung-Han Lee; Amishi Yogesh Shah; Drew Rasco; Arpit Rao; Matthew H Taylor; et al 出版日期:2021-06-16 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)